alternatives to glp 1 agonists TrimRX TrimRX | GLP-1 vs. Other
Description
GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes
C., Dludla P
These outcomes lead to the remodeling of the extracellular matrix, oxidative stress, inflammation, cardiomyocyte apoptosis, fibrosis, and metabolic abnormalities [55]
Increases lipid oxidation, promoting fat breakdown rather than storage
One of these was GIP which Turner took back to Surrey University where he had moved to from the Royal Free Hospital
HFpEF, heart failure with preserved ejection fraction
